Role of Nitric-Oxide Synthase, Free Radicals, and Protein Kinase C δ in Opioid-Induced Cardioprotection
- 1 June 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 301 (3) , 1012-1019
- https://doi.org/10.1124/jpet.301.3.1012
Abstract
Opioids generate free radicals that mediate protection in isolated cultured cardiomyocytes. We hypothesize that the nature of these radicals is nitric oxide, and that nitric oxide activates the protein kinase C (PKC) δ isoform. Through this signal transduction pathway, opiates protect cardiomyocytes during hypoxia and reoxygenation. Cell viability was quantified in chick embryonic ventricular myocytes with propidium iodide. Oxygen radicals were quantified using a molecular probe, 2′,7′-dichlorofluorescin diacetate (DCFH-DA). After a 10-min infusion of the opioid δ receptor agonist BW373U86 (BW; 2 or 20 pM) and a 10-min drug-free period, cells were subjected to hypoxia for 1 h followed by reoxygenation for 3 h. BW produced a concentration-dependent reduction in cardiomyocyte death (2 pM, 35.3 ± 3.9%, n = 5; 20 pM, 21.5 ± 4.0%, n = 8, p < 0.05 versus controls) and attenuated oxidant stress compared with controls (43.3 ± 4.2%, n = 8). The increase in DCFH-DA oxidation with BW before hypoxia was abolished by the specific nitric-oxide synthase inhibitors nitro-l-arginine methyl ester (l-NAME) orNG-monomethyl-l-arginine (l-NMMA) (100 μM each). l-NAME orl-NMMA blocked the protective effects of BW. BW selectively increased the activity of PKC δ isoform in the particulate fraction, and its protection was abolished by the selective PKC δ inhibitor rottlerin (1 μM). Similar to BW, infusion with 5 μM of the nitric oxide donorS-nitroso-N-acetylpenicillamine (SNAP) reduced cardiomyocyte death (24.6 ± 3.7, n = 8), and this protection was blocked by chelerythrine or rottlerin. Chelerythrine and rottlerin had no effect on BW-generated oxygen radicals before hypoxia, but they abolished the protection of SNAP. The nature of DCFH oxidation produced by opioid δ receptor stimulation is nitric oxide. Nitric oxide mediates cardioprotection via activating PKC δ in isolated myocytes.This publication has 38 references indexed in Scilit:
- The Late Phase of PreconditioningCirculation Research, 2000
- Morphine and Anandamide Stimulate Intracellular Calcium Transients in Human Arterial Endothelial Cells: Coupling to Nitric Oxide Release1Abbreviations: NO–Nitric oxide, cNOS–constitutive nitric oxide synthase.1Cellular Signalling, 1999
- The nitric oxide hypothesis of late preconditioningBasic Research in Cardiology, 1998
- A Selective ε-Protein Kinase C Antagonist Inhibits Protection of Cardiac Myocytes from Hypoxia-induced Cell DeathJournal of Biological Chemistry, 1997
- Role of Protein Kinase C in Ischemic Preconditioning: Player or Spectator?Circulation Research, 1996
- Alkaloid delta Agonist BW373U86 Increases Hypoxic ToleranceAnesthesia & Analgesia, 1996
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Comparison of Trypan Blue Dye Exclusion and Fluorometric Assays for Mammalian Cell Viability DeterminationsBiotechnology Progress, 1993
- Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain.Proceedings of the National Academy of Sciences, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976